Platelet Transfusion
American Society of Clinical OncologyPublished: January 16, 2018
- Key Points
- Preparation of Platelet Products
- Prevention of Rh Alloimmunization
- Leukoreduction
- Prophylactic vs Therapeutic Platelet Transfusion
- Platelet Transfusion Threshold in Patients with Hematologic Malignancies
- Platelet Transfusion Threshold in the Setting of Hematopoietic Stem Cell Transplantation
- Platelet Transfusion in Patients with Chronic, Stable, Severe Thrombocytopenia Who Are Not Receiving Active Treatment
- Platelet Transfusion Threshold in Patients With Solid Tumors
- Platelet Count at which Surgical or Invasive Procedures May Be Performed
- Monitoring for Refractoriness to Platelet Transfusion
- Managing Refractoriness to Platelet Transfusion
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.